1-11 of 11
Marjolein van der Poel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pacritinib in transplant-eligible myelofibrosis: Final analysis of the phase 2 HOVON-134 trial

Free
Ruben Van Dijck, Bronno van der Holt, Annoek Broers, Ellen Meijer, Timothy Devos, Mette Hazenberg, Marjolein Van Der Poel, Dimitri Breems, Lien Deleu, Christel van Hooije, Jan J. Cornelissen, Nicolaas Schaap, Peter te Boekhorst
Journal: Blood
Blood (2025) 146 (Supplement 1): 6068.
https://doi.org/10.1182/blood-2025-6068
Published: 2025
Journal Articles

Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7

Free
Lori Leslie, Gerardo Musuraca, Pau Abrisqueta, Joshua Brody, Jacob Christensen, Alexander Fosså, Marjolein Van Der Poel, Joost Vermaat, Fritz Offner, David Belada, Jian Mei, Isil Altintas, Malene Risum, Aidan Reilly, Liwei Wang, Lorenzo Falchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 465.
https://doi.org/10.1182/blood-2025-465
Published: 2025
Journal Articles

Transformed FL shows improved survival after CAR T-cell therapy compared to de novo LBCL, but early transformation (<12 months) defines a poor-risk subgroup: Results from a nationwide cohort

Free
Hilde Van Der Galien, Pim Mutsaers, Margot Jak, Marjolein Van Der Poel, Marije Nijk, Kees Meijer, Marieke Tienstra, Kylie Keijzer, Janneke De Boer, Astrid Demandt, Amaria Vledder, Anne Spanjaart, Elise Pennings, Maria Kuipers, Marie José Kersten, Jaap Van Doesum, Anne Niezink, Joost Vermaat, Suzanne Van Dorp, Tom Van Meerten
Journal: Blood
Blood (2025) 146 (Supplement 1): 959.
https://doi.org/10.1182/blood-2025-959
Published: 2025
Journal Articles

BMS-986458, a first-in-class, bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6) in patients with Relapsed/Refractory (R/R) non-Hodgkin lymphoma (NHL): Updated results from the Phase 1 dose escalation study

Free
Franck Morschhauser, David Qualls, Jennifer Lue, Anastasios Stathis, Marcel Nijland, Avyakta Kallam, Jörg Bittenbring, Guillaume Cartron, Noémie Lang, Marjolein Van Der Poel, Loic Ysebaert, Vladan Vucinic, Alejandro Martin Garcia-Sancho, Antonio Rueda Dominguez, Noelia Purroy, Berengere De Moucheron, Xiaosong Li, Carla Guarinos, Joseph Burnett, Alicia Benítez Rondán, Michael Pourdehnad, Jessica Voetsch, Diego Sobradillo, Jean-Marie Michot
Journal: Blood
Blood (2025) 146 (Supplement 1): 480.
https://doi.org/10.1182/blood-2025-480
Published: 2025
Journal Articles

High risk of bleeding following CAR T-cell therapy: Insights from the dutch “Follow that CAR!” registry

Free
Amica Ko, Pim Mutsaers, Lukas Van Kleij, Frank Leebeek, Amaria Vledder, Elise Pennings, Anne Spanjaart, Janneke De Boer, Astrid Demandt, Jaap Van Doesum, Suzanne Van Dorp, Margot Jak, Maria Kuipers, Tom Van Meerten, Marjolein Van Der Poel, Joost Vermaat, Marie José Kersten, Mandy Lauw
Journal: Blood
Blood (2025) 146 (Supplement 1): 315.
https://doi.org/10.1182/blood-2025-315
Published: 2025
Journal Articles

Elevation of fetal hemoglobin is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC leukemia group, gimema and german MDS study group

Free
Julia Stomper, Michal Kicinski, Tobias Ma, Thomas Meyer, Sylvain Chantepie, Richard Noppeney, Mario Luppi, Ernesta Audisio, Laimonas Griškevičius, Andreas Neubauer, Robin Foà, Walter Van der Velden, Anna Candoni, Radovan Vrhovac, Gianluca Gaidano, Marjolein Van Der Poel, Mels Hoogendoorn, Stéphanie Antunes, Frederic Baron, Adriano Venditti, Joop Jansen, Pierre Wijermans, Gerwin A. Huls, Michael Lübbert
Journal: Blood
Blood (2025) 146 (Supplement 1): 1709.
https://doi.org/10.1182/blood-2025-1709
Published: 2025
Journal Articles

Bispecific T-Cell Engagers for B-Cell NON-Hodgkin Lymphoma Patients before Allogeneic Stem Cell Transplantation. a Study on Behalf Od Geth-TC

Free
Marta Peña, Jacopo Mariotti, Stefania Bramanti, Nicole Fabbri, Angel Serna, Yasmina Serroukh, Marjolein van der Poel, Ya-Ting Hsu, Ana Jimenez Ubieto, Blanca Rius-Sansalvador, Mi Kwon, Carlos Panizo, Jose Maria Sanchez Pina, Carlos Solano, Lucia Lopez Corral, Raquel Saldaña, Carmen Albo Lopez, Andres Sanchez Salinas, Jose A. Perez-Simon, Jaime Sanz, David Valcarcel Ferreiras, Montserrat Rovira, Leyre Bento De Miguel, Alberto Mussetti, Anna Maria Sureda Balari
Journal: Blood
Blood (2023) 142 (Supplement 1): 4899.
https://doi.org/10.1182/blood-2023-181815
Published: 2023
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

Free
A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

Efficacy and Safety of Valemetostat Monotherapy in Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results of the Phase 2 VALENTINE-PTCL01 Study

Free
Steven M. Horwitz, Koji Izutsu, Neha Mehta-Shah, Raul Cordoba, Stefan K. Barta, Emmanuel Bachy, Giuseppe Gritti, Eric Jacobsen, Shigeru Kusumoto, Yann Guillermin, Anca Prica, Dok Hyun Yoon, Eva Domingo Domenech, Jie Wang, Jin Seok Kim, Kate Cwynarski, Marjolein van der Poel, Ai Inoue, Jin Jin, Sutan Wu, Keiko Nakajima, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 302.
https://doi.org/10.1182/blood-2023-179304
Published: 2023
Journal Articles

No Discernable Dysfunction of Peripheral T-Cells and NK-Cells Despite Distinct Phenotypes in MYC Rearranged Versus Non Rearranged B-Cell Lymphoma Patients

Free
A. Vera de Jonge, Carolien Duetz, Wassilis S.C Bruins, Charlotte L.B.M. Korst, Rosa Rentenaar, Meliha Cosovic, Merve Eken, Inoka Twickler, Marcel Nijland, Marjolein Van Der Poel, Koen de Heer, Clara Klerk, Leonie Strobbe, Margriet Oosterveld, Rinske Boersma, Harry R. Koene, Erik van Werkhoven, Martine E.D. Chamuleau, Tuna Mutis
Journal: Blood
Blood (2023) 142 (Supplement 1): 1653.
https://doi.org/10.1182/blood-2023-180734
Published: 2023
Journal Articles

Epcoritamab Monotherapy Provides Deep and Durable Responses Including Minimal Residual Disease (MRD) Negativity: Novel Subgroup Analyses in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Free
Tycel Phillips, Catherine Thieblemont, Herve Ghesquieres, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana A. Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Nurgul Kilavuz, Mariana Cota Stirner, David Soong, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliot, Martin Hutchings, Pieternella Lugtenburg
Journal: Blood
Blood (2022) 140 (Supplement 1): 9443–9445.
https://doi.org/10.1182/blood-2022-158245
Published: 2022